MDS Virtual Congress 2020 - FINAL PROGRAM - www.mdscongress.org
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
FINAL PROGRAM MDS Virtual Congress 2020 SEPTEMBER 12 – SEPTEMBER 16 www.mdscongress.org
MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
TABLE OF CONTENTS
Welcome.............................................................................................................2 Daily Schedule....................................................................................................9
About MDS..........................................................................................................3 Schedule-at-a-Glance.........................................................................................9
Purpose, Mission and Goals.................................................................................3 Virtual Congress Session Definitions.................................................................10
MDS Officers (2019-2021)...................................................................................3 Friday, September 11, 2020 ..............................................................................11
MDS International Executive Committee.............................................................4 Saturday, September 12, 2020 .........................................................................11
MDS Virtual Congress 2020 Task Force.................................................................4 Sunday, September 13, 2020 ............................................................................12
Congress Scientific Program Committee..............................................................4 Monday, September 14, 2020 ..........................................................................18
Congress Local Organizing Committee................................................................4 Tuesday, September 15, 2020 ...........................................................................22
Past-Presidents...................................................................................................4 Wednesday, September 16, 2020......................................................................26
International Medical Society for Motor Disturbances Past-Presidents................4 Non-CME Educational Activities........................................................................28
MDS International Secretariat.............................................................................4 MDS Special Interest Group Curated Sessions....................................................30
Virtual Congress Information..............................................................................5 Abstract Poster Information..............................................................................32
Exhibition............................................................................................................5 Virtual Guided Poster Tours...............................................................................33
Official Language................................................................................................5 Faculty Listing...................................................................................................34
Registration........................................................................................................5 Acknowledgements..........................................................................................37
Virtual Congress Events.......................................................................................5 Membership Information..................................................................................39
Awards Information............................................................................................6
CME Information.................................................................................................8
www.mdscongress.org 1
MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
WELCOME
Dear Colleagues,
We are excited to share this MDS Virtual Congress with you. In this first ever virtual congress on movement disorders, you can expect over 30 hours of educational
content through our virtual platform, including plenary sessions, teaching courses and access to the accepted abstracts.
The Society made the difficult decision to replace the in-person meeting in Philadelphia with a virtual meeting, and by doing so, is rising to the occasion after the
COVID-19 crisis in order to fulfill its mission. This meeting will be open to healthcare professionals across the globe and will allow delegates an opportunity to access
the full International Congress Scientific Program content through a virtual platform without concern for health, welfare or travel.
The MDS Virtual Congress 2020 scientific sessions, sponsored symposia, virtual exhibits, and poster sessions will be available on demand for free until October 1,
2020 for those participants who have registered by September 16, 2020. After October 1, 2020 the Virtual Congress will continue to be available on demand for MDS
Members for a limited time.
Although we will not meet together in Philadelphia this September, I am proud to see the MDS community come together virtually to achieve our mission.
Claudia Trenkwalder
President, International Parkinson and Movement Disorder Society, 2019-2021
RETURN TO TABLE OF CONTENTS www.mdscongress.org 2
MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
ABOUT MDS
The International Parkinson and Movement Disorder Society (MDS) is a MDS OFFICERS (2019-2021)
professional society of clinicians, scientists, and other healthcare professionals President
who are interested in Parkinson’s disease, related neurodegenerative and Claudia Trenkwalder
neurodevelopmental disorders, hyperkinetic movement disorders, and Germany
abnormalities in muscle tone and motor control.
PURPOSE, MISSION AND GOALS
Purpose: President-Elect
Francisco Cardoso
The objective and mission of the Society shall be to advance the neurological
Brazil
sciences pertaining to Movement Disorders; to improve the diagnosis and
treatment of patients; to operate exclusively for scientific, scholarly and
educational purposes; to encourage research; to provide forums, such as medical
journals, scientific symposia and International Congresses, for sharing ideas and Secretary
for advancing the related clinical and scientific disciplines; to encourage interest Bastiaan Bloem
and participation in the activities of the Society among healthcare and allied Netherlands
professionals and scientists; and to collaborate with other related professional
and lay organizations.
Mission and Goals:
Secretary-Elect
To disseminate knowledge about Movement Disorders by: Charles Adler
• Providing educational programs for clinicians, scientists and the general USA
public designed to advance scientific and clinical knowledge about
Movement Disorders
• Sponsoring International Congresses and Symposia on Movement
Disorders T reasurer
• Collaborating with other international organizations and lay groups Louis Tan
• Publishing journals, videotapes and other collateral materials committed Singapore
to high scientific standards and peer review
To promote research into causes, prevention and treatment of Movement
Disorders by: T reasurer-Elect
• Using the Society’s influence and resources to enhance support for research Irene Litvan
• Facilitating the dissemination of information about research USA
• Encouraging the training of basic and clinical scientists in Movement
Disorders and related disorders
For the purposes of favorably affecting the care of patients with Movement
Disorders, the Society will provide expertise, advice and guidance to: Past-President
• Regulatory agencies to assist them in the approval process of safe and Christopher Goetz
effective therapeutic interventions USA
• The public (media) and patient support groups by informing them of new
research and therapeutic advances
• Governments to assist them in the development of policies that affect
support of research and patient care
• Educational efforts to assist in developing standards of training in the
specialty
RETURN TO TABLE OF CONTENTS www.mdscongress.org 3
MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
ABOUT MDS
MDS INTERNATIONAL EXECUTIVE COMMITTEE CONGRESS LOCAL ORGANIZING COMMITTEE
Shengdi Chen Chair: Matthew Stern, USA
Mark Edwards Co-Chair: Andrew Siderowf, USA
Cristian Falup-Pecurariu Nabila Dahodwala, USA
Joaquim Ferreira Andres Deik, USA
Marina de Koning-Tijssen Jill Farmer, USA
Alice Nieuwboer Pedro Gonzalez-Alegre, USA
D. James Surmeier Dan Kremens, USA
Pille Taba Tsao-Wei Liang, USA
Mayela Rodriguez-Violante Meredith Spindler, USA
Ruey-Meei Wu Dan Weintraub, USA
Allison Willis, USA
MDS VIRTUAL CONGRESS 2020 TASK FORCE
Chairs: Vincenzo Bonifati, Netherlands PAST-PRESIDENTS
Chairs: Oscar Gershanik, Argentina 2017-2019 Christopher Goetz, USA
Chairs: Claudia Trenkwalder, Germany 2015-2017 Oscar Gershanik, Argentina
Francisco Cardoso, Brazil 2013-2015 Matthew Stern, USA
Margherita Fabbri, Italy 2011-2013 Günther Deuschl, Germany
Hyder Jinnah, USA 2009-2011 Philip Thompson, Australia
Andrew Siderowf, USA 2007-2009 Anthony Lang, Canada
Matthew Stern, USA 2005-2006 Andrew Lees, United Kingdom
Louis Tan, Singapore 2003-2004 C. Warren Olanow, USA
2001-2002 Werner Poewe, Austria
CONGRESS SCIENTIFIC PROGRAM COMMITTEE 1999-2000 Mark Hallett, USA
Chair: Vincenzo Bonifati, Netherlands 1997-1998 Eduardo Tolosa, Spain
Co-Chair: Andrew Siderowf, USA 1995-1996 Joseph Jankovic, USA
Orlando Barsottini, Brazil 1991-1994 C. David Marsden, United Kingdom
Roongroj Bhidayasiri, Thailand 1988-1991 Stanley Fahn, USA
Per Borghammer, Denmark
Francisco Cardoso, Brazil INTERNATIONAL MEDICAL SOCIETY FOR MOTOR
Pietro Cortelli, Italy DISTURBANCES PAST-PRESIDENTS
Alberto Espay, USA 1993-1994 C. Warren Olanow, USA
Jennifer Friedman, USA 1991-1992 Bastian Conrad, Germany
Jennifer Goldman, USA 1989-1990 Mark Hallett, USA
Tove Henriksen, Denmark 1987-1988 Mario Manfredi, Italy
Etienne Hirsch, France 1985-1986 C. David Marsden, United Kingdom
Beomseok Jeon, South Korea
Andrea Kühn, Germany MDS INTERNATIONAL SECRETARIAT
Shen-Yang Lim, Malaysia International Parkinson and Movement Disorder Society
Karen Marder, USA 555 East Wells Street, Suite 1100
Wassilios Meissner, France Milwaukee, WI 53202-3823 USA
Tiago Outeiro, Germany Tel: +1 414-276-2145
Maria Stamelou, Greece Fax: +1 414-276-3349
Carolyn Sue, Australia Email: info@movementdisorders.org
Ryosuke Takahashi, Japan Website: www.movementdisorders.org
Claudia Trenkwalder, Germany
Ad-Hoc Member: Terry Ellis, USA
Ad-Hoc Member: Oscar Gershanik, Argentina
Ad-Hoc Member: Hyder Jinnah, USA
Ad-Hoc Member: Ron Postuma, Canada
Ad-Hoc Member: Veronica Santini, USA
RETURN TO TABLE OF CONTENTS www.mdscongress.org 4
MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
VIRTUAL CONGRESS INFORMATION
ACCESS VIRTUAL PLATFORM OFFICIAL LANGUAGE
Participants can access the virtual platform at The official language of the MDS Virtual Congress 2020 is English.
https://virtual.mdscongress.org.
REGISTRATION
In order to log in to the virtual platform, you will need the following
information: Email Address and Registration ID The MDS Virtual Congress 2020 scientific sessions, sponsored symposia, virtual
exhibits, and the virtual poster hall will be available on-demand for free until
If you have any problems logging in, please contact congress@ October 1, 2020 for those participants who have registered by September 16,
movementdisorders.org 2020. After October 1, 2020 the Virtual Congress will continue to be available on
demand for MDS Members for a limited time.
EXHIBITION
Participants will have the opportunity to visit the Virtual Exhibit Hall beginning
on September 12, 2020.
VIRTUAL CONGRESS EVENTS
WELCOME CEREMONY MDS VIRTUAL VIDEO CHALLENGE
Friday, September 11, 2020 Sunday, September 13, 2020
Time: 15:00 - 16:00 GMT Time: 19:30 - 22:30 GMT
All participants are encouraged to attend the Virtual Congress Welcome Ceremony. Monday, September 14, 2020
MDS President Claudia Trenkwalder and other MDS leaders will introduce this Time: 2:00 - 5:00 GMT
inaugural event and give a preview of what to expect throughout the week. Please join Masters of Ceremony Anthony Lang and Kapil Sethi as they host world-
In celebration of the achievements of leaders in the field of Movement Disorders, renowned Movement Disorders experts in guiding participants through unique
the following awards will be presented during the Welcome Ceremony: Movement Disorder cases. The cases will be presented by representatives from
Movement Disorder Centers around the world and discussed by Movement Disorder
The President’s Distinguished Service Award Experts. Awards will be given for the most interesting and challenging cases.
The President’s Distinguished Service Award is chosen directly by the MDS Country pride will add an enjoyable spirit of competition to this event. The goal
President in recognition of long and distinguished service to MDS. of this session is for participants to learn from a series of unusual, very interesting
patients and see how senior experts approach these types of challenging cases.
MDS Honorary Membership Awards
The MDS Honorary Membership Award Program recognizes individuals who See page 17 for further details on the MDS Virtual Video Challenge.
have made extraordinary contributions to the field of Movement Disorders or PLENARY SESSION 204: NEUROSCIENCE BRIDGES
otherwise to the Society. Recipients of this prestigious award shall be entitled to
lifetime MDS Membership. In this session, world-renowned neuroscientists provide overviews of their clinical
or basic research, on topics of broad interest and relevance for the advancement
Paper of the Year Awards of knowledge on the nervous system in physiology and pathology.
The Movement Disorders Research and Review Papers of the Year awards were Understanding Disease Associated Microglia
chosen by the Journal’s Editors and Editorial Board to recognize quality work in Neurodegeneration
being submitted by authors and the important articles published in the Journal.
The winning articles were selected from five finalists for each category, all which Beth Stevens, USA
shared a high scientific level and interest. At the conclusion of this presentation, participants should be
better able to understand microglia states and functions in health
MDS LEAP Program – Class of 2019 Graduates and disease.
The MDS LEAP Program has been established to provide leadership training to
support the growth, development and success of early career movement disorders Inner Workings of Channelrhodopsins and Brains
specialists, while maximizing their contributions to the goals and objectives of Karl Deisseroth, USA
MDS. This 12-month program encompasses the development of leadership skills
At the conclusion of this presentation, participants should be
through mentored development and a two-day didactic skills training program
better able to summarize the evolution of optogenetics, and how
(which takes place immediately prior to the International Congress). this technology can promote understanding of the functions and
dysfunctions of the brain.
RETURN TO TABLE OF CONTENTS www.mdscongress.org 5
MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
AWARDS INFORMATION
PRESIDENT’S DISTINGUISHED SERVICE AWARD MDS-AOS Section:
The President’s Distinguished Service Award is chosen directly by the MDS Roopa Rajan, MD, DM
President in recognition of long and distinguished service to the International Hanan Khalil, PhD
Parkinson and Movement Disorder Society (MDS). Cholpon Shambetova, MD
Please join MDS in unveiling and congratulating the 2020 President’s Woong-Woo Lee, MD
Distinguished Service Award MDS-ES Section:
recipient(s) during the Welcome Ceremony on September 11, at 15:00 GMT. Gesine Respondek, MD
Aurélie Méneret, MD, PhD
MDS HONORARY MEMBERSHIP AWARD Antonella Macerollo, MD, MRCP
The MDS Honorary Membership Award Program recognizes individuals that David Breen MRCP, PhD
have made extraordinary contributions to the field of Movement Disorders or
otherwise to The Society. Recipients of this prestigious award shall be entitled to MDS-PAS Section:
lifetime MDS Membership. Catalina Cerquera-Cleves, MD, MSc
Please join MDS in congratulating the 2020 Honorary Membership Award Christopher Stephen, Mb ChB, MRCP
recipients, Kailash Bhatia and Caroline Tanner, during the Welcome Ceremony Malco Rossi, MD, PhD
launching in the MDS Virtual Congress platform on Friday, September 11 at Michelle Hyczy de Siqueira Tosin, RN, MSN
15:00 GMT. MDS-Africa
MDS LEAP PROGRAM – CLASS OF 2019 Oluwadamilola Ojo, MBBS
GRADUATES Biniyam Ayele, MD
The MDS LEAP Program has been established to provide leadership training PAPER OF THE YEAR AWARDS
to support the growth, development and success of early career movement
The Movement Disorders Research and Review Papers of the Year awards were
disorders specialists, while maximizing their contributions to the goals and
chosen by the Journal’s
objectives of MDS. This 12-month program encompasses the development
of leadership skills through mentored development and a two-day didactic Editors and Editorial Board to recognize quality work being submitted by authors
skills training program (which takes place immediately prior to the and the important articles published in the Journal. The Paper of the Year
International Congress). Awards will be presented during the Welcome Ceremony on September 11.
Please join MDS in congratulating all contributing authors of the 2019-2020
Paper of the Year Awards.
Research Article of the Year Award
Randomized Controlled Trial of Exercise on Objective and Subjective Sleep in
Parkinson’s Disease
Amy Amara, Kimberly Wood, Allen Joop, Raima Memon, Jennifer Pilkington,
S. Tuggle, John Reams, Matthew Barrett, David Edwards, Arthur Weltman,
Christopher Hurt, Gary Cutter, Marcas Bamman
Review Article of the Year Award
Value of in vivo α‐synuclein deposits in Parkinson’s disease: A systematic review
and meta‐analysis
Kazuto Tsukita, Haruhi Sakamaki-Tsukita, Kanta Tanaka, Toshihiko Suenaga,
Ryosuke Takahashi
Leap Class of 2019
The 2019 LEAP Graduates will be honored at the Welcome Ceremony on Friday,
September 11.
RETURN TO TABLE OF CONTENTS www.mdscongress.org 6
MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
AWARDS INFORMATION
PRESIDENTIAL LECTURE AWARDS JUNIOR AWARDS
Please join MDS in honoring the 2020 Presidential Lecture Award recipients, MDS Junior Awards are presented in recognition of significant contribution to
Werner Poewe and Hiroshi Shibasaki, during Plenary Session 201: clinical or basic science research in the field of Movement Disorders, to qualified
Presidential Lectures, on September 13, from 12:00 – 14:00 GMT. individuals submitting top ranked abstracts for the MDS Congress. Please join
us in honoring this year’s awardees during the Presidential Lectures session on
Stanley Fahn Lecture Award September 13, from 12:00 – 14:00 GMT.
The Stanley Fahn Lecture Award was created to recognize an outstanding scholar
Rachael Lawson, United Kingdom
and role-model clinician in the field of Movement Disorders. The selected
Predicting dementia in the first 6 years of Parkinson’s disease in the ICICLE-PD
lecturer must show evidence of exceptional contributions which have resulted
cohort
in better understanding of the cause, diagnosis, or treatment of Movement
Disorders, and have translated into meaningful improvements in the standard of ChenChen Zhang, People’s Republic of China
clinical practice. Neural activity in the subthalamic nucleus in association with reward/loss
processing in patients with Parkinson’s disease
Werner Poewe, Austria
Diagnosing Parkinson’s Disease - From the Street to the Bench Full texts of the Junior Award recipient abstracts are available on the 2020 MDS
Virtual Congress platform, and in the MDS Congress app.
Learning Objective: Understand the challenges and pitfalls in
making a clinical diagnosis of Parkinson’s disease and the role
of imaging and other biomarkers in enhancing early diagnosis
and diagnostic accuracy
C. David Marsden Lecture Award
The C. David Marsden Lecture Award was created to recognize an outstanding
scholar and inspiring neuroscientist in the field of Movement Disorders. The
selected lecturer must show evidence of exceptional contributions which have
resulted in better understanding of the neurobiology of Movement Disorders,
and have translated into tangible improvements in clinical therapy and/or
providing insight into normal brain function in the control of movement.
Hiroshi Shibasaki, Japan
Myoclonus is Telling How Our Brain Works
Learning Objective: Understand the physiological mechanism
of cortical myoclonus.
RETURN TO TABLE OF CONTENTS www.mdscongress.org 7
MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
CME INFORMATION
TARGET AUDIENCE EVALUATIONS
Clinicians, researchers, post-doctoral fellows, medical residents, medical Evaluations are considered part of the course. All evaluations must be completed
students, allied health professionals with an interest in current clinical trends by Thursday, October 1, 2020. The evaluation link is available within the session’s
and approaches for the diagnosis and treatment of movement disorders. description on the MDS Virtual Congress platform and at www.mdscongress.org.
OBJECTIVES CLAIMING CME
1. Evaluate the pharmacological and non-pharmacological management Please visit www.mdscongress.org to claim CME for this activity. Please be
options available for Parkinson’s disease and other movement disorders advised CME must be claimed by November 16, 2020. You will require the
2. Discuss the diagnostic approaches and tools available for Parkinson’s registration ID number found in your confirmation email. Please contact
disease and other movement disorders education@movementdisorders.org with any questions.
3. Describe the pathogenesis and neurobiology of Parkinson’s disease and FACULTY DISCLOSURES
other movement disorders All individuals in control of content for the MDS International Congress are
required to disclose all relevant financial relationships with commercial interests
ACCREDITATION STATEMENT
as defined by the ACCME. Disclosure information is available online at
This activity has been planned and implemented in accordance with the www.mdscongress.org and via the MDS International Congress app.
accreditation requirements and policies of the Accreditation Council for
Continuing Medical Education (ACCME). The International Parkinson and CONTENT VALIDITY STATEMENT
Movement Disorder Society is accredited by the ACCME to provide continuing All recommendations involving clinical medicine in MDS activities are based
medical education for physicians. on evidence that is accepted within the profession of medicine as adequate
justification for their indications and contraindications in the case of patients. All
CREDIT DESIGNATION
scientific research referred to, reported or used in CME in support or justification
The International Parkinson and Movement Disorder Society designates of patient care recommendations conforms to the generally accepted standards
this education activity for a maximum of 28.5 AMA PRA Category 1 Credits™. of experimental design, data collection and analysis. Activities that promote
Physicians should claim only credit commensurate with the extent of their recommendations, treatment or manners of practicing medicine not within the
participation in the activity. definition of CME or are knowing to have risks or dangers that outweigh the
benefits or are knowing to be ineffective in the treatment of patients do not
SATISFACTORY COMPLETION
constitute valid CME.
Participants must complete an evaluation for each session they attend to receive
continuing medical education credit. Your chosen session(s) must be attended in
their entirety. Partial credit of individual sessions is not available.
RETURN TO TABLE OF CONTENTS www.mdscongress.org 8
MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
SCHEDULE-AT-A-GLANCE
FRIDAY SATURDAY SUNDAY MONDAY TUESDAY WEDNESDAY
September 11 September 12 September 13 September 14 September 15 September 16
2:00
Therapeutic Plenary Session KEY
2:30
Encore Presentation Virtual MDS Video Challenge
3:00 CME Accredited
2:00 - 4:00 GMT Encore Presentation
3:30 Sessions
2:00 - 5:00 GMT
4:00 Break 4:00 - 4:30 GMT Non-CME
4:30 Educational
Therapeutic Plenary Session Activities
5:00
Encore Presentation
5:30 Sponsored Symposia
4:30 - 6:30 GMT (non-CME)
6:00 MDS-AOS Regional Assembly 6:00 - 6:30 GMT
6:30 Break 6:30 - 7:00 GMT MDS Activities
7:00 and Events
Therapeutic Plenary Session
7:30 Breaks
Encore Presentation
8:00
7:00 - 9:00 GMT
8:30
9:00 Break 9:00 - 9:30 GMT
9:30
Therapeutic Plenary Session
10:00
Encore Presentation
10:30
9:30 - 11:30 GMT
11:00
11:30 Break 11:30 - 12:00 GMT
12:00
12:30
Therapeutic Plenary Session Plenary Session Plenary Session Plenary Session Plenary Session
12:00 - 14:00 GMT 12:00 - 14:00 GMT 12:00 - 14:00 GMT 12:00 - 13:45 GMT 12:00 - 14:00 GMT
13:00
13:30
Break MDS Business Meeting MDS-ES Regional Assembly Break Break Break
14:00 14:00 - 14:30 GMT 14:00 - 14:30 GMT 14:00 - 14:30 GMT 14:00 - 14:30 GMT 13:45 - 14:30 GMT 14:00 - 14:30 GMT
14:30 Parallel Parallel
Science of Science of
Sessions / Sessions /
15:00 Parallel Sessions / Teaching Industry (non- Industry (non-
Welcome Ceremony Therapeutic Plenary Session Teaching Teaching Plenary Sessions
Courses CME) Session CME) Session
15:00 - 16:00 GMT 14:30 - 16:30 GMT Courses Courses 14:30 - 16:30 GMT
15:30 14:30 - 16:30 GMT 14:30 - 16:30 14:30 - 16:30
14:30 - 16:30 14:30 - 16:30
GMT GMT
16:00 GMT GMT
16:30
Sponsored Symposia Sponsored Symposia Sponsored Symposia Sponsored Symposia
16:30 - 17:30 GMT 16:30 - 17:30 GMT 16:30 - 17:30 GMT 16:30 - 17:30 GMT
17:00
MDS-Africa Regional Assembly
17:30 Break 17:30 - 18:00 GMT Break 17:30 - 18:00 GMT Break 17:30 - 18:00 GMT
17:30 - 18:00 GMT
18:00 Skills Workshops / Special Topics Skills Workshops / Special Topics Skills Workshops / Special Topics
in Movement Disorders / in Movement Disorders / in Movement Disorders /
18:30
Therapeutic Plenary Session Video Sessions Video Sessions Video Sessions
18:00 - 20:00 GMT 18:00 - 19:30 GMT 18:00 - 19:30 GMT 18:00 - 19:30 GMT
19:00
19:30
20:00 Break 20:00 - 20:30 GMT
20:30
Virtual MDS Video Challenge
21:00 19:30 - 22:30 GMT
Therapeutic Plenary Session
21:30 20:30 - 22:30 GMT
MDS-PAS Regional Assembly
22:00
22:30 - 23:00 GMT
RETURN TO TABLE OF CONTENTS www.mdscongress.org 9MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
VIRTUAL CONGRESS SESSION DEFINITIONS
CME Accredited Sessions Non-CME Accredited Educational Activities
2020 Virtual Congress Themed Sessions: At each annual International Science of Industry Sessions: These interactive sessions will provide
Congress, the Congress Scientific Program Committee selects a theme that attendees with a non-CME educational opportunity to learn about novel
is highlighted throughout the meeting. This year’s theme, The Combined therapeutic agents under development by industry. Sessions may incorporate
Multidisciplinary Approach to Movement Disorders, will be showcased with basic scientists or clinicians working in industry, and topics may address
international experts serving as faculty. Meeting participants can elect to attend the biological rationale or development process for specific therapeutics in
any or all of these sessions. Themed sessions are designated in the program development within the field of Movement Disorders.
with .
Sponsored Symposia
NEW in 2020: “Neuroscience Bridges” Plenary Session: In this session
world-renowned neuroscientists provide overviews of their clinical or basic Sponsored Symposia: These company-based informational sessions
research, on topics of broad interest and relevance for the advancement of provide attendees with non-CME educational opportunities to learn the latest
knowledge on the nervous system in physiology and pathology. in therapeutics.
Controversies: This Plenary Session is designed to involve all Virtual Congress Video Challenge
participants. Content is prepared to stimulate interest and debate among a Video Challenge: The goal of this session is for attendees to learn from a series
panel of experts. Views from several angles will be addressed as discussion of of unusual patients and observe how senior experts approach a challenging
pre-selected “hot” topics will be open for debate among the panelists. case. A world-renowned panel of Movement Disorders experts guide
“Highlights for 2020: Looking Towards 2021” Plenary Session: In this attendees through unique Movement Disorder cases as they are presented by
session MDS experts present compilations of the hottest clinical and basic representatives from Movement Disorder centers around the world.
research articles published in the past year in the whole field of the Movement
Disorders, and expected to impact heavily on the future research.
Parallel Sessions: These concurrent sessions provide an in-depth summary
VIRTUAL CONGRESS FACULTY ROLES
of new clinical and basic research findings, state-of-the-art treatment options,
and future strategies on a variety of focused topics within the field of Movement Chair: Facilitates the learnings of the session; ensures that learning
Disorders. objectives are met during the presentation(s), and engages the learners
as needed.
Plenary Sessions: These sessions provide an overview of the latest clinical
and basic science research findings and state-of-the-art information relating to CSPC Liaison: Develops the session from the onset; provides guidance
topics of broad interest within the field of Movement Disorders. to ensure that the learning objectives are met; interacts with Speakers /
Presenters to ensure presentations are well integrated and overlap
Skills Workshops: These concurrent sessions provide practical illustrations is minimized.
of clinical or scientific techniques relevant to the field of Movement Disorders
through video examples and equipment demonstrations. Speakers: Creates and delivers the presentation materials, and participates
in the dialogue of the session.
Special Topics in Movement Disorders: These interactive sessions address
“hot” topics in science or medicine using a variety of different formats that may
include lectures, video presentations, and audience interaction.
Teaching Courses: These educational programs provide up-to-date 2020 VIRTUAL CONGRESS THEME
information focused on a single topic. The sessions highlight both the clinical At each annual International Congress, the Congress Scientific Program
and basic science of topics of relevance to Movement Disorder specialists. The Committee selects a theme that is highlighted throughout the meeting.
sessions are unique in providing a syllabus that includes a review of the topic This year’s theme is The Combined Multidisciplinary Approach to Movement
and the presentation slides. Disorders. International experts will serve as faculty, and the meeting
Therapeutic Plenary Sessions: These sessions provide an overview of the participants can elect to attend any or all of these sessions.
latest, state-of-the-art treatment options in the diagnosis and management of
Themed sessions
Parkinson’s disease and other movement disorders.
Video Sessions: These concurrent sessions focus on video demonstrations to
provide an overview of clinical movement disorders.
RETURN TO TABLE OF CONTENTS www.mdscongress.org 10MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
FRIDAY, SEPTEMBER 11, 2020
Welcome Ceremony
15:00 - 16:00 GMT
All participants are encouraged to attend the Virtual Congress Welcome
Ceremony.
SATURDAY, SEPTEMBER 12, 2020
MDS-AOS Regional Assembly MDS Business Meeting
6:00 - 6:30 GMT 14:00 - 14:30 GMT
All participants from Asia and Oceania are encouraged to attend. All participants are encouraged to attend.
101: Therapeutic Plenary Session 102: Therapeutic Plenary Session
Updates on Medical Management Strategies Parkinson’s Disease: Non-Motor Aspects
for Parkinson’s Disease: Motor Aspects 14:30 – 16:30 GMT
12:00 - 14:00 GMT Chairs: Angelo Antonini, Italy
Chairs: Matthew B. Stern, USA Daniel Weintraub, USA
Pille Taba, Estonia Neuropsychiatric Features
Early Pharmacologic Management Anette Schrag, United Kingdom
Oscar Gershanik, Argentina Dysautonomia
Rehabilitation Strategies Horacio Kaufmann, USA
Alice Nieuwboer, Belgium Sleep and Fatigue
Medical Management Strategies for Advancing Disease Ron Postuma, Canada
Patients CSPC Liaison: Jennifer Goldman, USA
Regina Katzenschlager, Austria
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health
CSPC Liaison: Shen-Yang Lim, Malaysia Professionals, Students/Residents/Trainees
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health At the conclusion of this session, participants should be better able to:
Professionals, Students/Residents/Trainees
1. Describe the neuropsychiatric aspects of Parkinson’s disease and their management
At the conclusion of this session, participants should be better able to: 2. Discuss the recognition and management of dysautonomia in Parkinson’s disease
1. Discuss current management of early-stage Parkinson’s disease 3. Summarize the symptoms and management of sleep and fatigue in
2. Review the role of rehabilitation, including physical, occupational and speech Parkinson’s disease
therapies, and exercise in Parkinson’s disease
3. Describe current medical management strategies for advancing Parkinson’s disease
(motor complications and other late-stage features)
RETURN TO TABLE OF CONTENTS www.mdscongress.org 11MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
SATURDAY, SEPTEMBER 12, 2020
103: Therapeutic Plenary Session 104: Therapeutic Plenary Session
Therapeutic Approaches to Chorea, Dystonia, Neurosurgical Management of Movement
and Myoclonus Disorders
18:00 – 20:00 GMT 20:30 – 22:30 GMT
Chairs: Francisco Cardoso, Brazil Chairs: Günther Deuschl, Germany
Eduardo Tolosa, Spain Andrea Kühn, Germany
Chorea Technical Advances for DBS Treatment
Ruth Walker, USA Jens Volkmann, Germany
Dystonia Long-term Effects of DBS on Motor and Non-Motor
Rachel Saunders-Pullman, USA Symptoms in Parkinson’s Disease
Myoclonus Patricia Limousin, United Kingdom
Yoshikazu Ugawa, Japan Alternative Strategies: Focused Ultrasound and Other
Lesioning Techniques in Movement Disorders
CSPC Liaison: Francisco Cardoso, Brazil
José Obeso, Spain
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health
Professionals, Students/Residents/Trainees CSPC Liaison: Andrea Kühn, Germany
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health
At the conclusion of this session, participants should be better able to:
Professionals, Students/Residents/Trainees
1. List the therapeutics options to manage patients with different types of chorea
2. Discuss the therapeutic management of dystonia At the conclusion of this session, participants should be better able to:
3. Summarize the therapeutic options for myoclonus 1. Discuss and apply new DBS techniques such as segmented leads for current steering,
imaging guided programming, VTA models
2. Discuss indications of DBS and explain motor and non-motor benefits and risks
3. Discuss the pros and cons of different surgical approaches in movement disorders
SUNDAY, SEPTEMBER 13, 2020
101: Therapeutic Plenary Session (Encore Presentation) 102: Therapeutic Plenary Session (Encore Presentation)
Updates on Medical Management Strategies Parkinson’s Disease: Non-Motor Aspects
for Parkinson’s Disease: Motor Aspects 4:30 – 6:30 GMT
2:00 – 4:00 GMT Chairs: Huifang Shang, People’s Republic of China
Chairs: Roongroj Bhidayasiri, Thailand Louis Tan, Singapore
Shengdi Chen, People’s Republic of China Neuropsychiatric Features
Early Pharmacologic Management Anette Schrag, United Kingdom
Oscar Gershanik, Argentina Dysautonomia
Rehabilitation Strategies Horacio Kaufmann, USA
Alice Nieuwboer, Belgium Sleep and Fatigue
Medical Management Strategies for Advancing Disease Ron Postuma, Canada
Patients CSPC Liaison: Jennifer Goldman, USA
Regina Katzenschlager, Austria
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health
CSPC Liaison: Shen-Yang Lim, Malaysia Professionals, Students/Residents/Trainees
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health At the conclusion of this session, participants should be better able to:
Professionals, Students/Residents/Trainees
1. Describe the neuropsychiatric aspects of Parkinson’s disease and their management
At the conclusion of this session, participants should be better able to: 2. Discuss the recognition and management of dysautonomia in Parkinson’s disease
1. Discuss current management of early-stage Parkinson’s disease 3. Summarize the symptoms and management of sleep and fatigue in
2. Review the role of rehabilitation, including physical, occupational and speech Parkinson’s disease
therapies, and exercise in Parkinson’s disease
3. Describe current medical management strategies for advancing Parkinson’s disease
(motor complications and other late-stage features)
RETURN TO TABLE OF CONTENTS www.mdscongress.org 12MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
SUNDAY, SEPTEMBER 13, 2020
103: Therapeutic Plenary Session (Encore Presentation) 201: Plenary Session
Therapeutic Approaches to Chorea, Dystonia, Presidential Lectures
and Myoclonus 12:00 – 14:00 GMT
7:00 – 9:00 GMT Chairs: Francisco Cardoso, Brazil
Chairs: Ruey-Meei Wu, Taiwan Claudia Trenkwalder, Germany
Victor Fung, Australia Stanley Fahn Lecture: Diagnosing Parkinson’s Disease -
Chorea From the Street to the Bench
Ruth Walker, USA Werner Poewe, Austria
Dystonia C. David Marsden Lecture: Myoclonus is Telling How Our
Rachel Saunders-Pullman, USA Brain Works
Myoclonus Hiroshi Shibasaki, Japan
Yoshikazu Ugawa, Japan Junior Award Lecture: Predicting dementia in the first 6
years of Parkinson’s disease in the ICICLE-PD cohort
CSPC Liaison: Francisco Cardoso, Brazil
Rachael Lawson, United Kingdom
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health
Professionals, Students/Residents/Trainees Junior Award Lecture: Neural activity in the subthalamic
nucleus in association with reward/loss processing in
At the conclusion of this session, participants should be better able to: patients with Parkinson’s disease
1. List the therapeutic options to manage patients with different types of chorea ChenChen Zhang, People’s Republic of China
2. Discuss the therapeutics management of dystonia
CSPC Liaisons: Vincenzo Bonifati, Netherlands
3. Summarize the therapeutic options for myoclonus Claudia Trenkwalder, Germany
104: Therapeutic Plenary Session (Encore Presentation) Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health
Professionals. Students/Residents/Trainees
Neurosurgical Management of Movement
Disorders At the conclusion of this session, participants should be better able to:
1. Understand the challenges and pitfalls in making a clinical diagnosis of Parkinson’s
9:30 - 11: 30 GMT
disease and the role of imaging and other biomarkers in enhancing early diagnosis
Chairs: Ritsuko Hanajima, Japan and diagnostic accuracy
Beomseok Jeon, South Korea
2. Understand the physiological mechanism of cortical myoclonus
Technical Advances for DBS Treatment
Jens Volkmann, Germany MDS-ES Regional Assembly
Long-term Effects of DBS on Motor and Non-motor 14:00 - 14:30 GMT
Symptoms in Parkinson’s Disease All participants from Europe are encouraged to attend.
Patricia Limousin, United Kingdom
Alternative Strategies: Focused Ultrasound and Other
Lesioning Techniques in Movement Disorders
José Obeso, Spain
CSPC Liaison: Andrea Kühn, Germany
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health
Professionals, Students/Residents/Trainees
At the conclusion of this session, participants should be better able to:
1. Discuss and apply new DBS techniques such as segmented leads for current steering,
imaging guided programming, VTA models
2. Discuss indications of DBS and explain motor and non-motor benefits and risks
3. Discuss the pros and cons of different surgical approaches in movement disorders
RETURN TO TABLE OF CONTENTS www.mdscongress.org 13MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
SUNDAY, SEPTEMBER 13, 2020
301: Parallel Session 303: Parallel Session
COVID -19 and Movement Disorders Update on Functional Movement Disorders
14:30 – 16:30 GMT 14:30 – 16:30 GMT
Chairs: Huifang Shang, People’s Republic of China
Chairs: Mark Edwards, United Kingdom
Indu Subramanian, USA
Mark Hallett, USA
Neurological Manifestations in patients with COVID-19
Phenomenology
Elena Moro, France
Francesca Morgante, United Kingdom
COVID-19 in Patients with Parkinson’s Disease or
Electrophysiology and Imaging
Movement Disorders
Tereza Serranova, Czech Republic
Alfonso Fasano, Canada
Psychological Aspects to Aetiology and Management
Caring of Patients with Movement Disorders in the
Timothy Nicholson, United Kingdom
COVID-19 Era
Esther Cubo, Spain CSPC Liaison: Beomseok Jeon, South Korea
CSPC Liaison: Buz Jinnah, USA Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health
Professionals, Students/Residents/Trainees
Recommended Audience: Clinical Academicians, Practitioners Non-Physician Health Professionals,
Students/Residents/Trainees At the conclusion of this session, participants should be better able to:
At the conclusion of this session, participants should be better able to: 1. Recognize the phenomenology of functional movement disorders
1. Summarize the current knowledge about the neurological manifestations and 2. Summarize the electrophysiological and imaging features of functional
neuropathology in subjects affected by the COVID-19 movement disorders
2. Summarize the clinical phenomenology and outcomes of the COVID-19 disease in 3. Discuss the psychopathology and management of functional movement disorders
patients with Parkinson’s disease and other movement disorders
304: Parallel Session
3. Discuss the impact of the COVID-19 pandemic on the clinical care of patients with
movement disorders, and the available strategies to ensure continuity of care and Update on Genetics of Movement Disorders
best outcomes 14:30 – 16:30 GMT
Chairs: Christine Klein, Germany
302: Parallel Session Carolyn Sue, Australia
MSA and Pure Autonomic Failure Parkinsonism
14:30 – 16:30 GMT Chin-Hsien Lin, Taiwan
Chairs: Howard Hurtig, USA Dystonia
Ryosuke Takahashi, Japan Patricia Maria Carvalho Aguiar, Brazil
Molecular Mechanisms Ataxia
Virginia Lee, USA Martin Paucar Arce, Sweden
The Challenge of Early Diagnosis Top Abstracts: Top Abstracts presented in this session can be found on page 32.
Wassilios Meissner, France CSPC Liaison: Carolyn Sue, Australia
Pure / Isolated Autonomic Failure Recommended Audience: Clinical Academicians, Practitioners, Non-Physician Health Professionals,
Lucy Norcliffe-Kaufmann, USA Students/Residents/Trainees
CSPC Liaisons: Pietro Cortelli, Italy At the conclusion of this session, participants should be better able to:
Ryosuke Takahashi, Japan 1. Summarize recently identified genes related to Parkinson’s disease and parkinsonism
Recommended Audience: Basic Scientists, Clinical Academicians, Students/Residents/Trainees 2. Summarize recently identified genes related to dystonia
At the conclusion of this session, participants should be better able to: 3. Summarize recently identified genes related to ataxia
1. Discuss the role of alpha-synuclein in the initiation and progression of
neurodegeneration across Parkinson’s disease and atypical parkinsonism
2. Recognize Multiple System Atrophy at an early stage
3. Recognize Pure/Isolated Autonomic failure and discuss its role in predicting the onset
of other synucleinopathies (MSA, DLB, PD)
RETURN TO TABLE OF CONTENTS www.mdscongress.org 14MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
SUNDAY, SEPTEMBER 13, 2020
305: Parallel Session 401: Teaching Course
Heterogeneity of Parkinson’s Disease: Clinical Cognitive and Psychiatric Issues in the
Phenotypes and Progression Parkinsonian Spectrum
14:30 – 16:30 GMT 14:30 – 16:30 GMT
Chairs: Nabila Dahodwala, USA Chairs: Cristian Falup-Pecurariu, Romania
Connie Marras, Canada James Morley, USA
Influence of the Genetic Determinants Apathy: Why, Who, and What to Do About It
Clemens Scherzer, USA Marcelo Merello, Argentina
Role of Environment, Lifestyle and Comorbidities It’s Not Just MCI / Dementia: The Many Cognitive
Connie Marras, Canada Changes in Parkinsonism
Lessons from Large Cohort Studies Madeleine Sharp, Canada
Rodolfo Savica, USA Parkinson’s Disease Treatments: How do They Change
Neuropsychiatric Symptoms?
Top Abstracts: Top Abstracts presented in this session can be found on page 32.
Daniel Weintraub, USA
CSPC Liaison: Claudia Trenkwalder, Germany
CSPC Liaison: Ron Postuma, Canada
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Students/Residents/
Trainees Recommended Audience: Clinical Academicians, Practitioners, Students/Residents/Trainees
At the conclusion of this session, participants should be better able to: At the conclusion of this session, participants should be better able to:
1. Discuss the influence of different genetic variants (rare/Mendelian, intermediate- 1. Discuss the pathophysiology, disease spectrum and management of apathy in
effects variants such as GBA and LRRK2-G2019S, and common GWAS variants) on parkinsonian conditions
phenotypes and progressions of Parkinson’s disease 2. Evaluate the broad spectrum of non-dementia cognitive changes in
2. Discuss the influence of environment, diet, exercise, comorbidities and inflammation parkinsonian conditions
on the heterogeneity of Parkinson’s disease 3. Differentiate treatment vs. disease-related effects on neuropsychiatric symptoms in
3. Discuss the potential of ongoing large longitudinal cohorts-studies to understand Parkinson’s disease
Parkinson’s disease heterogeneity
402: Teaching Course
306: Parallel Session Dystonia, Ataxia, and Tics
Huntington’s Disease Continuum and Non- 14:30 – 16:30 GMT
Huntington’s Choreas Chairs: Cynthia Comella, USA
14:30 – 16:30 GMT Susanne Schneider, Germany
Chairs: Joaquim Ferreira, Portugal My Approach to Dystonia
Amanda Krause, South Africa Susanne Schneider, Germany
The Natural History of Huntington’s Disease My Approach to Ataxia
G. Bernhard Landwehrmeyer, Germany José Luiz Pedroso, Brazil
When Genetic Testing is Negative: Huntington’s My Approach to Tic Disorders
Phenocopies Tamara Pringsheim, Canada
Amanda Krause, South Africa CSPC Liaison: Ron Postuma, Canada
A Critical Appraisal of Clinical Trials in Huntington’s Recommended Audience: Clinical Academicians, Practitioners, Students/Residents/Trainees
Disease
Joaquim Ferreira, Portugal At the conclusion of this session, participants should be better able to:
1. Describe the phenomenology and diagnostic approach to dystonia
CSPC Liaison: Francisco Cardoso, Brazil
2. Describe the phenomenology and diagnostics approach to ataxia
Recommended Audience: Clinical Academicians, Practitioners, Non-Physician Health Professionals, 3. Summarize the phenomenology and diagnostic approach to tic disorders
Students/Residents/Trainees
At the conclusion of this session, participants should be better able to: MDS-Africa Regional Assembly
1. Discuss the natural history of Huntington’s Disease 17:30 - 18:00 GMT
2. List the differential diagnosis of Huntington’s Disease phenocopies All participants from the African continent are encouraged to attend.
3. Appraise recent clinical trials in Huntington’s Disease
RETURN TO TABLE OF CONTENTS www.mdscongress.org 15MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
SUNDAY, SEPTEMBER 13, 2020
501: Skills Workshop 504: Skills Workshop
A Multidisciplinary Approach for Phenomenology of Movement Disorders for
Palliative Care Young Neurologists: Semiological Tricks and
18:00 – 19:30 GMT Pitfalls
This session aims to help providers identify and manage palliative care needs, collaborate with other 18:00 – 19:30 GMT
allied healthcare team members, and develop advance care planning with patients, families and their In this interactive session, the faculty will discuss tricks and maneuvers they employ in clinical practice
caregivers. for the detection and examination of movement disorders.
Stefan Lorenzl, Germany Mona Obaid, Saudi Arabia
Janis Miyasaki, Canada Mayela Rodriguez Violante, Mexico
CSPC Liaison: Claudia Trenkwalder, Germany CSPC Liaison: Oscar Gershanik, Argentina
Recommended Audience: Clinical Academicians, Practitioners, Non-Physician Health Professionals, Recommended Audience: Practitioners, Students/Residents/Trainees
Students/Residents/Trainees
At the conclusion of this session, participants should be better able to:
At the conclusion of this session, participants should be better able to: 1. Explore the phenomenology of movement disorders
1. Recognize the relevance of palliative care in movement disorders 2. Apply semiological tricks to better detect and examine movement disorders
2. Develop a multidisciplinary approach to the management of patients in advanced care
601: Special Topics in Movement Disorders
502: Skills Workshop
Big Data Analytics in Clinical Research for
DBS and Functional Communication in Movement Disorders
Parkinson’s Disease: Insights and Intervention 18:00 – 19:30 GMT
18:00 – 19:30 GMT
In this session the Faculty will discuss the impact of big data analytics in the current clinical research on
In this interactive session, the faculty will examine the impact of Deep Brain Stimulation on speech Parkinson’s disease and other movement disorders, as well as the potential implications of the research
intelligibility in Parkinson’s disease. Evidence-based interventions will be compared to optimize findings in the clinical management.
functional communication.
Ivo Dinov, USA
Elina Tripoliti, United Kingdom Allison Willis, USA
Michelle Troche, USA
CSPC Liaison: Roongroj Bhidayasiri, Thailand
CSPC Liaison: Terry Ellis, USA
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Students/Residents/
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health Trainees
Professionals, Students/Residents/Trainees
At the conclusion of this session, participants should be better able to:
At the conclusion of this session, participants should be better able to: 1. Describe the concept of big data analytics and the impact in clinical research in the
1. Examine the impact of Deep Brain Stimulation on speech intelligibility in field of Movement Disorders
Parkinson’s disease 2. Discuss findings from studies based on big data analytics, and their potential
2. Compare treatment strategies to optimize functional communication in implications in the clinical management
Parkinson’s disease
602: Special Topics in Movement Disorders
503: Skills Workshop
Revisiting the Role of Non-Neuronal Cells in
Imaging in Parkinson’s Disease Parkinson’s Disease
18:00 – 19:30 GMT 18:00 – 19:30 GMT
In this interactive session, the faculty will review the nuts and bolts of how radioisotope imaging, MRI,
In this interactive session, the faculty will discuss recent data suggesting that brain non-neuronal
and ultrasonography are used for diagnosis and prognostication in Parkinson’s disease.
cells, including glial and inflammatory cells, are involved in the pathogenesis and pathophysiology of
Marios Politis, United Kingdom Parkinson’s disease .
Klaus Seppi, Austria Antonella Consiglio, Spain
CSPC Liaison: Per Borghammer, Denmark David Sulzer, USA
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health CSPC Liaison: Etienne Hirsch, France
Professionals, Students/Residents/Trainees
Recommended Audience: Basic Scientists, Clinical Academicians, Students/Residents/Trainees
At the conclusion of this session, participants should be better able to:
At the conclusion of this session, participants should be better able to:
1. Describe how PET and SPECT are used for the diagnosis, prognostication, and as
1. Discuss the roles for non-neuronal cells in the pathophysiology of Parkinson’s disease
progression markers of Parkinson’s disease
2. Describe the putative roles for non-neuronal cells in the pathogenesis
2. Describe the application of anatomical and functional MRI, and ultrasonography in the
diagnosis, prognostication, and as progression markers of Parkinson’s disease
RETURN TO TABLE OF CONTENTS www.mdscongress.org 16MDS Virtual
Congress 2020
SEPTEMBER 12 –
SEPTEMBER 16
SUNDAY, SEPTEMBER 13, 2020
701: Video Session MDS Video Challenge (non CME)
Gait Disorders 19:30 – 22:30 GMT
18:00 – 19:30 GMT Please join Masters of Ceremony Anthony Lang and Kapil Sethi as they host world-renowned
In this interactive session, participants will gain knowledge on different gait disorders through Movement Disorders experts in guiding participants through unique Movement Disorder cases.
illustrative videos. Key features of gait disorders and different treatment strategies will be discussed, The cases will be presented by representatives from Movement Disorder Centers around the world
including surgical interventions. and discussed by Movement Disorder Experts. Awards will be given for the most interesting and
challenging cases. Country pride will add an enjoyable spirit of competition to this event. The goal of
Nir Giladi, Israel this session is for participants to learn from a series of unusual, very interesting patients and see how
Evzen Ruzicka, Czech Republic senior experts approach these types of challenging cases.
CSPC Liaison: Andrea Kühn, Germany Featured Experts:
Recommended Audience: Basic Scientists, Clinical Academicians, Practitioners, Non-Physician Health Bettina Balint, Germany
Professionals, Students/Residents/Trainees Orlando Barsottini, Brazil
Kailash Bhatia, United Kingdom
At the conclusion of this session, participants should be better able to: Francisco Cardoso, Brazil
1. Review the clinical features of normal gait and recognize key abnormalities of gait Roberto Erro, Italy
disorders Alberto Espay, USA
2. Recognize specific dysfunction in gait disorders, discuss differential diagnosis and the Alfonso Fasano, Canada
respective therapeutic management Jennifer Friedman, USA
Victor Fung, Australia
702: Video Session Christos Ganos, Germany
Tardive Syndromes and Other Drug Induced Dan Healy, Ireland
Movement Disorders Marina de Koning-Tijssen, Netherlands
Manju Kurian, United Kingdom
18:00 – 19:30 GMT
Tim Lynch, Ireland
In this interactive session, the faculty will demonstrate iatrogenic movement disorders in a case-based Stephen Reich, USA
format, highlighting acute, chronic, and tardive syndromes, emphasizing phenotypic features that can Maria Stamelou, Greece
be overlooked or misattributed to other disorders. Pearls and pitfalls of drug-related complications will
be discussed.
Hubert Fernandez, USA
Deborah Hall, USA
CSPC Liaison: Alberto Espay, USA
Recommended Audience: Clinical Academicians, Practitioners, Non-Physician Health Professionals,
Students/Residents/Trainees
At the conclusion of this session, participants should be better able to:
1. Recognize typical and atypical forms of tardive syndromes and distinguish from
mimics
2. Identify clinical clues associated with drug-induced movement disorders
RETURN TO TABLE OF CONTENTS www.mdscongress.org 17You can also read
